These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 9112750

  • 1. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis.
    Fendrick AM, Chernew ME, Hirth RA, Bloom BS.
    Yale J Biol Med; 1996; 69(2):187-95. PubMed ID: 9112750
    [Abstract] [Full Text] [Related]

  • 2. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
    Fendrick AM, McCort JT, Chernew ME, Hirth RA, Patel C, Bloom BS.
    Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH, Warbasse L, Brenner C.
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [Abstract] [Full Text] [Related]

  • 4. Alternative management strategies for patients with suspected peptic ulcer disease.
    Fendrick AM, Chernew ME, Hirth RA, Bloom BS.
    Ann Intern Med; 1995 Aug 15; 123(4):260-8. PubMed ID: 7611591
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis.
    You JH, Wong PL, Wu JC.
    Scand J Gastroenterol; 2006 Jan 15; 41(1):21-9. PubMed ID: 16373272
    [Abstract] [Full Text] [Related]

  • 6. Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective?
    Breuer T, Graham DY.
    Am J Gastroenterol; 1999 Mar 15; 94(3):725-9. PubMed ID: 10086658
    [Abstract] [Full Text] [Related]

  • 7. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
    Sonnenberg A.
    Am J Gastroenterol; 1996 Sep 15; 91(9):1773-7. PubMed ID: 8792696
    [Abstract] [Full Text] [Related]

  • 8. The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage.
    Ofman J, Wallace J, Badamgarav E, Chiou CF, Henning J, Laine L.
    Am J Gastroenterol; 2002 Aug 15; 97(8):1941-50. PubMed ID: 12190158
    [Abstract] [Full Text] [Related]

  • 9. The health economics of Helicobacter pylori infection.
    Moayyedi P.
    Best Pract Res Clin Gastroenterol; 2007 Aug 15; 21(2):347-61. PubMed ID: 17382282
    [Abstract] [Full Text] [Related]

  • 10. [Cost-effectiveness analysis of the eradication of Helicobacter pylori as treatment for duodenal ulcer].
    Fernández Muñoz J, López de Andrés A, Zapater Hernández P, Abad Santos F.
    An Med Interna; 1998 Oct 15; 15(10):515-22. PubMed ID: 9844225
    [Abstract] [Full Text] [Related]

  • 11. Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment?
    Pohl H, Finlayson SR, Sonnenberg A, Robertson DJ.
    Aliment Pharmacol Ther; 2005 Sep 15; 22(6):529-37. PubMed ID: 16167969
    [Abstract] [Full Text] [Related]

  • 12. [Diagnosis of Helicobacter pylori infections--how, when and in whom?].
    Wildner-Christensen M, Schaffalitzky de Muckadell OB.
    Ugeskr Laeger; 2000 Jun 26; 162(26):3743-7. PubMed ID: 10925639
    [Abstract] [Full Text] [Related]

  • 13. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
    Groeneveld PW, Lieu TA, Fendrick AM, Hurley LB, Ackerson LM, Levin TR, Allison JE.
    Am J Gastroenterol; 2001 Feb 26; 96(2):338-47. PubMed ID: 11232673
    [Abstract] [Full Text] [Related]

  • 14. Clinical utility and cost effectiveness of Helicobacter pylori testing for patients with duodenal and gastric ulcers.
    Greenberg PD, Koch J, Cello JP.
    Am J Gastroenterol; 1996 Feb 26; 91(2):228-32. PubMed ID: 8607485
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of initial noninvasive therapy in pediatric patients presenting with suspected ulcer disease.
    Olson AD, Fendrick AM, Deutsch D, Chernew ME, Hirth RA, Patel C, Bloom BS.
    Gastrointest Endosc; 1996 Nov 26; 44(5):554-61. PubMed ID: 8934161
    [Abstract] [Full Text] [Related]

  • 16. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
    Chiba N, Lahaie R, Fedorak RN, Bailey R, Veldhuyzen van Zanten SJ, Bernucci B.
    Can Fam Physician; 1998 Jul 26; 44():1481-8. PubMed ID: 9678277
    [Abstract] [Full Text] [Related]

  • 17. Management strategies for duodenal ulcer in India in the helicobacter pylori era: an economic analysis.
    Ghoshal UC, Das A.
    Natl Med J India; 2002 Jul 26; 15(3):140-4. PubMed ID: 12186326
    [Abstract] [Full Text] [Related]

  • 18. Management of Helicobacter pylori infection.
    Meurer LN, Bower DJ.
    Am Fam Physician; 2002 Apr 01; 65(7):1327-36. PubMed ID: 11996414
    [Abstract] [Full Text] [Related]

  • 19. Acid peptic diseases in the era of Helicobacter pylori.
    Schoenfeld PS.
    Lippincotts Prim Care Pract; 1998 Apr 01; 2(4):358-68. PubMed ID: 9709081
    [Abstract] [Full Text] [Related]

  • 20. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD.
    J Clin Gastroenterol; 2008 Jul 01; 42(6):744-9. PubMed ID: 18277886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.